Literature DB >> 1826787

The effect of ondansetron on cognitive performance in the marmoset.

A M Domeney1, B Costall, P A Gerrard, D N Jones, R J Naylor, M B Tyers.   

Abstract

The 5-HT3 receptor antagonist, ondansetron, was administered to marmosets to determine its effect on their performance in a Wisconsin General Test Apparatus using an object discrimination reversal learning task. Briefly, this comprised a test situation in which marmosets were required to select a food rewarded object to reach criterion in performance (this was termed the initial discrimination task); the rewarded object was then changed (in the same test session) and the marmoset was required to abandon its recently learned strategy to gain reward by selection of the second object (this was termed the reversal task). At doses of 1-10 ng/kg SC b.i.d. ondansetron improved performance in both the initial discrimination and reversal tasks. This was indicated as a reduction in the number of trials required to reach criterion, a reduction in choice latency time and a reduction in the number of errors made in each test session. Higher doses of ondansetron impaired performance as measured by several criteria. The major conclusion of this study is, therefore, that ondansetron at low doses is able to improve the performance of marmosets in a cognitive task. This would support the concept that a 5-HT3 receptor antagonist can act as a cognitive enhancer.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1826787     DOI: 10.1016/0091-3057(91)90606-3

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  15 in total

Review 1.  Alzheimer's disease and age-related memory decline (preclinical).

Authors:  Alvin V Terry; Patrick M Callahan; Brandon Hall; Scott J Webster
Journal:  Pharmacol Biochem Behav       Date:  2011-02-24       Impact factor: 3.533

2.  Comparison of the effects of the 5-HT3 receptor antagonists WAY-100579 and ondansetron on spatial learning in the water maze in rats with excitotoxic lesions of the forebrain cholinergic projection system.

Authors:  H Hodges; P Sowinski; J J Turner; A Fletcher
Journal:  Psychopharmacology (Berl)       Date:  1996-05       Impact factor: 4.530

Review 3.  The non-antiemetic uses of serotonin 5-HT3 receptor antagonists. Clinical pharmacology and therapeutic applications.

Authors:  A J Greenshaw; P H Silverstone
Journal:  Drugs       Date:  1997-01       Impact factor: 9.546

4.  The selective 5-HT3 receptor antagonist, WAY100289, enhances spatial memory in rats with ibotenate lesions of the forebrain cholinergic projection system.

Authors:  H Hodges; P Sowinski; J D Sinden; C A Netto; A Fletcher
Journal:  Psychopharmacology (Berl)       Date:  1995-02       Impact factor: 4.530

5.  Lack of effects of 5-HT3 antagonists on normal and morphine-attenuated sexual behaviours in female and male rats.

Authors:  S A Tanco; N V Watson; B B Gorzalka
Journal:  Experientia       Date:  1993-03-15

Review 6.  Reversal learning as a measure of impulsive and compulsive behavior in addictions.

Authors:  Alicia Izquierdo; J David Jentsch
Journal:  Psychopharmacology (Berl)       Date:  2011-11-29       Impact factor: 4.530

7.  Reversal of visual attentional dysfunction following lesions of the cholinergic basal forebrain by physostigmine and nicotine but not by the 5-HT3 receptor antagonist, ondansetron.

Authors:  J L Muir; B J Everitt; T W Robbins
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

8.  5-HT3 receptor ligands lack modulatory influence on acetylcholine release in rat entorhinal cortex.

Authors:  R M Johnson; G T Inouye; R M Eglen; E H Wong
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-03       Impact factor: 3.000

9.  The effect of a 5-HT3 receptor antagonist, ondansetron, on brain stimulation reward, and its interaction with direct and indirect stimulants of central dopaminergic transmission.

Authors:  A M Montgomery; I C Rose; L J Herberg
Journal:  J Neural Transm Gen Sect       Date:  1993

10.  Ondansetron improves cognitive performance in the Morris water maze spatial navigation task.

Authors:  D J Fontana; S E Daniels; C Henderson; R M Eglen; E H Wong
Journal:  Psychopharmacology (Berl)       Date:  1995-08       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.